Most physicians agree that patients should know how much they’re going to pay for treatment before deciding on a plan. According to a survey of breast cancer surgeons, 87 percent agreed with this. Yet, it’s only a minority of physicians who claim they have cost-of-care discussions with their patients.
2025
AI diagnostic platform improves early detection of skin cancer
If detected early, the prognosis for skin cancer is excellent. An innovative full-body scanner linked to an AI diagnostic platform is set to help with early detection of melanoma. In just six minutes, it automatically scans a patient’s entire body, providing a risk assessment for each anomalous change found in the skin.
Scientists discover new weapon in the fight against skin cancer
Scientists attribute this rise partly to increased exposure to ultraviolet (UV) radiation from the sun and tanning beds. Unlike most cancers, which predominantly affect older individuals, melanoma is also common in people under 30. Despite significant progress in treatment, many patients experience resistance to available therapies, making new approaches crucial.
1 in 5 Patients Experience Skin Toxicity With Nivolumab/Relatlimab
In a study of patients with advanced melanoma, the prevalence of cutaneous immune–related adverse events (cirAEs) associated with nivolumab/relatlimab combination therapy was 21.5%, with rash and maculopapular eruption being most common.